The UB research found that sociodemographic and economic factors were associated with increased readmissions for patients treated for heart failure, pneumonia, acute myocardial infarction, and acute exacerbation of COPD.
Jason Sprowl, PhD, assistant professor, pharmaceutical sciences, is the recipient of a multi-year, $2.3 million grant from the National Institutes of Health to explore how TKIs inactivate specific drug transporting proteins responsible for clearance of many co-administered medications.
In the coming weeks, the City of Buffalo will welcome 350 Afghan evacuees, including men, women and children. The UB School of Pharmacy and Pharmaceutical Sciences is asking for help to provide urgently needed resources.
Donald Mager, BS ’91, PharmD ’00 and PhD ’02, professor and vice chair, Department of Pharmaceutical Sciences, has been appointed a Fellow of the International Pharmaceutical Federation (FIP). Mager was recognized for his leadership in systems pharmacology and pharmacodynamics, and for his strong history of international collaboration and service.